|
CNTA
|
Centessa Pharmaceuticals plc
|
US
|
NASDAQ
|
|
CNTX
|
Context Therapeutics Inc.
|
US
|
NASDAQ
|
|
COEP
|
Coeptis Therapeutics Holdings, Inc
|
US
|
NASDAQ
|
|
COGT
|
Cogent Biosciences, Inc.
|
US
|
NASDAQ
|
|
CRDF
|
Cardiff Oncology, Inc.
|
US
|
NASDAQ
|
|
CRIS
|
Curis, Inc.
|
US
|
NASDAQ
|
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CSBR
|
Champions Oncology, Inc.
|
US
|
NASDAQ
|
|
CSTL
|
Castle Biosciences, Inc.
|
US
|
NASDAQ
|
|
CTIC
|
Cell Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CUE
|
Cue Biopharma, Inc.
|
US
|
NASDAQ
|
|
CVM
|
Cel-Sci Corporation
|
US
|
AMEX
|
|
CYCC
|
Cyclacel Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CYCCP
|
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock
|
US
|
NASDAQ
|
|
CYH
|
Community Health Systems, Inc.
|
US
|
NYSE
|
|
CYT
|
Cyteir Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DAWN
|
Day One Biopharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
DBTX
|
Decibel Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
DFFN
|
Diffusion Pharmaceuticals Inc.
|
US
|
NASDAQ
|